Home » Newsletters » BioWorld Science

BioWorld Science

April 14, 2015

View Archived Issues

Researchers describe novel RNAi-based bone anabolic strategy

SNP in ARNT2 gene linked to Asperger's syndrome

REGENXBIO licenses vector delivery technologies for mucopolysaccharidosis gene therapies

Novel assay for DNA methylation predicts outcome in AML patients

Teijin Pharma develops bifunctional M3 antagonist and beta2-agonist compounds

Pierre Fabre and CNRS patent DNMT inhibitors

Scientists describe IMP3 expression and chromosome 12p abnormalities in PMTT

Novel RORgt modulators identified for inflammatory diseases

Heptares Therapeutics describes discovery of mGlu5 receptor negative allosteric modulator

The Scripps Research Institute receives NCI grant to target Hippo-YAP pathway

Hydra Biosciences and Boehringer Ingelheim collaborate on TRP inhibitors for renal diseases

Voyager Therapeutics completes financing to fund AAV gene therapy development

Neothetics initiates phase III trials of LIPO-202 for reduction of subcutaneous abdominal fat

Ichor and Janssen to develop DNA vaccines for chronic HBV infection

Berg and collaborators aim to discover first biomarker for pancreatic cancer

AEternaZentaris plans confirmatory phase III trial of Macrilen in GHD diagnosis

Sthamin1 as a biomarker to distinguish ESS and ULMS from LM

Midatech and Dana-Farber Cancer Institute to collaborate on glioblastoma nanomedicines

Merck & Co. discloses HIV integrase inhibitors

Toray reports new analgesics

The CHDI Foundation discloses KMO inhibitors

University of Cologne presents apoptosis-inducing compounds

MolMed exercises option right on San Raffaele Hospital's CAR-CD44v6 project

Phase IIb trial of Nefecon for primary IgA nephropathy meets primary endpoint

Bayer expands copanlisib program with three new trials

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...